Humana Income After Taxes 2012-2026 | HUM
Humana annual/quarterly income after taxes history and growth rate from 2012 to 2026. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Humana income after taxes for the quarter ending March 31, 2026 was $1.200B, a 6.61% decline year-over-year.
- Humana income after taxes for the twelve months ending March 31, 2026 was $1.220B, a 33.33% decline year-over-year.
- Humana annual income after taxes for 2025 was $1.305B, a 0.23% decline from 2024.
- Humana annual income after taxes for 2024 was $1.308B, a 48.65% decline from 2023.
- Humana annual income after taxes for 2023 was $2.547B, a 9.23% decline from 2022.
|
Humana Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2025 | $1,305 |
| 2024 | $1,308 |
| 2023 | $2,547 |
| 2022 | $2,806 |
| 2021 | $2,869 |
| 2020 | $3,293 |
| 2019 | $2,693 |
| 2018 | $1,672 |
| 2017 | $2,448 |
| 2016 | $614 |
| 2015 | $1,276 |
| 2014 | $1,147 |
| 2013 | $1,231 |
| 2012 | $1,222 |
| 2011 | $1,419 |
|
Humana Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2026-03-31 | $1,200 |
| 2025-12-31 | $-762 |
| 2025-09-30 | $220 |
| 2025-06-30 | $562 |
| 2025-03-31 | $1,285 |
| 2024-12-31 | $-646 |
| 2024-09-30 | $496 |
| 2024-06-30 | $695 |
| 2024-03-31 | $763 |
| 2023-12-31 | $-516 |
| 2023-09-30 | $842 |
| 2023-06-30 | $966 |
| 2023-03-31 | $1,255 |
| 2022-12-31 | $-13 |
| 2022-09-30 | $1,190 |
| 2022-06-30 | $695 |
| 2022-03-31 | $934 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $1,516 |
| 2021-06-30 | $555 |
| 2021-03-31 | $807 |
| 2020-12-31 | $-280 |
| 2020-09-30 | $1,305 |
| 2020-06-30 | $1,803 |
| 2020-03-31 | $465 |
| 2019-12-31 | $514 |
| 2019-09-30 | $688 |
| 2019-06-30 | $928 |
| 2019-03-31 | $563 |
| 2018-12-31 | $353 |
| 2018-09-30 | $635 |
| 2018-06-30 | $193 |
| 2018-03-31 | $491 |
| 2017-12-31 | $184 |
| 2017-09-30 | $499 |
| 2017-06-30 | $650 |
| 2017-03-31 | $1,115 |
| 2016-12-31 | $-401 |
| 2016-09-30 | $450 |
| 2016-06-30 | $311 |
| 2016-03-31 | $254 |
| 2015-12-31 | $101 |
| 2015-09-30 | $314 |
| 2015-06-30 | $431 |
| 2015-03-31 | $430 |
| 2014-12-31 | $145 |
| 2014-09-30 | $290 |
| 2014-06-30 | $344 |
| 2014-03-31 | $368 |
| 2013-12-31 | $-30 |
| 2013-09-30 | $368 |
| 2013-06-30 | $420 |
| 2013-03-31 | $473 |
| 2012-12-31 | $192 |
| 2012-09-30 | $426 |
| 2012-06-30 | $356 |
| 2012-03-31 | $248 |
| 2011-12-31 | $199 |
| 2011-09-30 | $445 |
| 2011-06-30 | $460 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Health Maintenance Organizations | $23.068B | $129.664B |
| Humana Inc. is a health care plan provider in the United States. The company provides health insurance benefits under Health Maintenance Organization, Private Fee-For-Service and Preferred Provider Organization plans. The company also provides other benefits with specialty products including dental, vision, and other supplementary benefits. Humana's medical and specialty insurance products allow members to access health care services primarily through its networks of health care providers. The company manages its business through the following segments: The Retail segment consists of Medicare benefits, which are marketed on a retail basis to individuals. The Group and Specialty segment comprises employer group commercial fully-insured medical and specialty health insurance benefits. The Healthcare Services - The segment consists of services offered to the company's health plan members as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UnitedHealth Group (UNH) | United States | $276.233B | 18.66 |
| Cigna Group (CI) | United States | $71.482B | 9.09 |
| Centene (CNC) | United States | $18.343B | 18.19 |
| Molina Healthcare (MOH) | United States | $7.599B | 13.70 |
| Select Medical Holdings (SEM) | United States | $2.030B | 14.23 |
| Joint (JYNT) | United States | $0.125B | 0.00 |
| Aethlon Medical (AEMD) | United States | $0.003B | 0.00 |